Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Hepatobiliary and Transplant Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Liver Int. 2019 Jun;39(6):1155-1164. doi: 10.1111/liv.13995. Epub 2019 Feb 21.
BACKGROUND & AIMS: Biliary strictures are common complications after orthotopic liver transplantation. Endoscopic retrograde cholangiography evolved as standard and percutaneous transhepatic cholangiodrainage as alternative therapy. This study analysed predictors of long-term success of biliary strictures after endoscopic retrograde cholangiography and/or percutaneous transhepatic cholangiodrainage and its impact on patient survival.
All adult patients with biliary strictures receiving endoscopic retrograde cholangiography and/or percutaneous transhepatic cholangiodrainage between 2009 and 2015 at the University Medical Center Hamburg-Eppendorf were retrospectively analysed. Potential predictors of long-term success (≥12 months) were identified by univariate and logistic regression analyses. Patient survival was analysed by Kaplan-Meier method and log-rank test.
Hundred and sixteen patients were treated with endoscopic retrograde cholangiography and/or percutaneous transhepatic cholangiodrainage, including 67 patients with anastomotic strictures, 22 with nonanastomotic strictures and 27 with both stricture types. Eighty-five patients received endoscopic retrograde cholangiography, 17 percutaneous transhepatic cholangiodrainage and 14 both techniques. Long-term success was achieved in 60 patients (52%). Predictors of treatment failure were a preinterventional C-reactive protein >8 g/dL in anastomotic strictures (P = 0.039) and a body mass index ≤21 kg/m in nonanastomotic strictures (P = 0.021). In patients who received endoscopic retrograde cholangiography only, balloon dilatation of anastomotic strictures with larger diameters favoured success (P = 0.015). Achievement of long-term success was associated with prolonged patient survival in anastomotic strictures (P = 0.036) and nonanastomotic strictures (P = 0.025), but not in combined strictures (P = 0.739).
In post-orthotopic liver transplantation biliary strictures treated by endoscopic retrograde cholangiography and/or percutaneous transhepatic cholangiodrainage, patient BMI and preinterventional C-reactive protein may influence prognosis. Endoscopic retrograde cholangiography with larger balloon diameter may favour success in anastomotic strictures. Long-term success by endoscopic retrograde cholangiography and/or percutaneous transhepatic cholangiodrainage is associated with superior survival in patients with anastomotic strictures and nonanastomotic strictures only.
胆道狭窄是原位肝移植后的常见并发症。内镜逆行胰胆管造影术已成为标准治疗方法,经皮经肝胆管引流术则作为替代疗法。本研究旨在分析内镜逆行胰胆管造影术和/或经皮经肝胆管引流术治疗胆道狭窄的长期成功率的预测因素及其对患者生存的影响。
回顾性分析 2009 年至 2015 年期间在汉堡大学医学中心接受内镜逆行胰胆管造影术和/或经皮经肝胆管引流术治疗的所有胆道狭窄的成年患者。采用单因素和逻辑回归分析确定长期成功(≥12 个月)的潜在预测因素。采用 Kaplan-Meier 方法和对数秩检验分析患者生存情况。
116 例患者接受了内镜逆行胰胆管造影术和/或经皮经肝胆管引流术治疗,其中吻合口狭窄 67 例,非吻合口狭窄 22 例,两种类型狭窄 27 例。85 例患者接受了内镜逆行胰胆管造影术,17 例患者接受了经皮经肝胆管引流术,14 例患者同时接受了两种技术治疗。60 例(52%)患者获得长期成功。吻合口狭窄患者治疗前 C 反应蛋白(CRP)>8 g/dL(P=0.039)和非吻合口狭窄患者 BMI≤21 kg/m²(P=0.021)是治疗失败的预测因素。仅接受内镜逆行胰胆管造影术治疗的患者中,吻合口狭窄的球囊扩张直径较大与成功相关(P=0.015)。在吻合口狭窄(P=0.036)和非吻合口狭窄(P=0.025)患者中,获得长期成功与患者生存时间延长相关,但在联合狭窄患者中(P=0.739)则无相关性。
在接受内镜逆行胰胆管造影术和/或经皮经肝胆管引流术治疗的肝移植后胆道狭窄患者中,患者 BMI 和治疗前 CRP 可能影响预后。较大直径的球囊扩张可能有利于吻合口狭窄的治疗成功。内镜逆行胰胆管造影术和/或经皮经肝胆管引流术的长期成功与吻合口狭窄和非吻合口狭窄患者的生存时间延长相关。